JESSICA WILSON: Open Payments
NPI 1942763727 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 12 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $131 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $435 |
| Novo Nordisk Inc | 2 | $209 |
| Gilead Sciences, Inc. | 1 | $146 |
| Ipsen Biopharmaceuticals, Inc | 1 | $131 |
| GlaxoSmithKline, LLC. | 2 | $84 |
Products named: REZDIFFRA, IQIRVO, Wegovy.
Industry payments across KS — which companies pay providers there.
